As post-stroke neurogenesis is known to be impaired in aged animals, we sought to expand our findings by assessing PEG-IGF-I treatment on post-stroke neurogenesis in in aged (22–24 month old) animals. The gene discussed is IGF1; the disease is stroke disorder.